Novo plans to launch oral Wegovy, or “Wegovy-in-a-pill,” in the U.S.
The drugmaker’s stock has climbed more than 36% this year
Eli Lilly’s blockbuster diabetes treatment Mounjaro topped expectations for the first quarter